Tributylstannane → N-(2-Benzyloxy-5-oxotetrahydrofuran-3-yl)-6,10-dioxo-octahydro-9-(3-phenylpropionylamino)-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxamide
Reaction equation
[O:1]=[C:2]1[CH2:8][CH2:7][C@H:6]([NH:9][C:10](=[O:19])[CH2:11][CH2:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)[C:5](=[O:20])[N:4]2[C@H:21]([C:25](O)=[O:26])[CH2:22][CH2:23][CH2:24][N:3]12.C(OC([NH:34][C@H:35]1[CH2:39][C:38](=[O:40])[O:37][CH:36]1[O:41][CH2:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1)=O)C=C.C([SnH](CCCC)CCCC)CCC.ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC>ClCCl.CN(C)C=O.C(OCC)(=O)C.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1>[CH2:42]([O:41][CH:36]1[CH:35]([NH:34][C:25]([CH:21]2[N:4]3[C:5](=[O:20])[CH:6]([NH:9][C:10](=[O:19])[CH2:11][CH2:12][C:13]4[CH:14]=[CH:15][CH:16]=[CH:17][CH:18]=4)[CH2:7][CH2:8][C:2](=[O:1])[N:3]3[CH2:24][CH2:23][CH2:22]2)=[O:26])[CH2:39][C:38](=[O:40])[O:37]1)[C:43]1[CH:44]=[CH:45][CH:46]=[CH:47][CH:48]=1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 4
Procedure
To a solution of (1S, 9S) 6,10-dioxo-octahydro-9-(3-phenyl-propionylamino)-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid (45a) (662 mg; 1.773 mmol) in dry dichloromethane (9 ml) and dry dimethyl formamide (3 ml) at room temperature was added bis(triphenylphosphine)palladium chloride (30 mg) and (3S, 2RS)-3-allyloxycarbonylamino-2-benzyloxy-5-oxotetrahydrofuran (Chapman, Biorg. Med. Chem. Lett., 2, pp. 613-18 (1992)) (568 mg; 1.95 mmol) followed by dropwise addition of tri-n-butyltin hydride (1.19 g; 4.09 mmol). 1-Hydroxy-benzotriazole (479 mg; 3.546 mmol) was added to the mixture and the mixture was cooled to 0° C. before addition of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (408 mg; 2.128 mmol). The mixture was stirred at room temperature for 3.25 h then diluted with ethyl acetate (50 ml), washed twice with dilute hydrochloric acid (20 ml), twice with saturated sodium bicarbonate (20 ml), once with brine then dried (MgSO4) and concentrated. The resulting oil was purified by flash chromatography (0-100% ethyl acetate/chloroform) to afford 810 mg (81%) of 46a as a mixture of anomers: mp. 92°-94° C.; IR (KBr) 3311, 1791, 1659, 1651, 1536; 1H NMR (CDCl3) δ 7.49, 6.56 (1H, 2d, J=6.7, 7.8), 7.29 (10H, m), 6.37, 6.18 (1H, 2d, J=7.7, 7.6), 5.56, 5.34 (1H, d, s, J=5.2), 5.08-4.47 (6H), 3.18-2.80 (5H), 2.62-2.28 (5H), 2.04-1.53 (5H). MS (FAB, m/z), 563 (M+ +1), 328, 149, 91.
Workup
- washwashed twice with dilute hydrochloric acid (20 ml), twice with saturated sodium bicarbonate (20 ml), once with brine
- dry with materialthen dried (MgSO4)
- concentrationconcentrated
- customThe resulting oil was purified by flash chromatography (0-100% ethyl acetate/chloroform)
Sources & evidence
- ORD record
- ord-63e1ecc205d04f77bd5cead47e6e3d54
- Source dataset
- uspto-grants-1997_08
- Patent number
- US05656627
Reaction notes
Loading…